Genmab Market Cap

Genmab has a market cap or net worth of $14.14 billion as of June 13, 2025. Its market cap has decreased by -22.90% in one year.

Market Cap

14.14B

Enterprise Value

10.84B

Revenue

3.23B

Ranking

n/a

PE Ratio

12.41

Stock Price

$224.30

Market Cap Chart

Since October 18, 2000, Genmab's market cap has increased from 415.12M to 14.14B, an increase of 3,306.86%. That is a compound annual growth rate of 15.38%.

Market Cap History

Date	Market Cap	% Change
Jun 13, 2025	14.14B	7.19%
Dec 30, 2024	13.19B	-36.79%
Dec 29, 2023	20.88B	-24.42%
Dec 30, 2022	27.62B	5.40%
Dec 30, 2021	26.20B	-1.50%
Dec 30, 2020	26.60B	83.75%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.60B
Veradigm	747.25M
Elite Pharmaceuticals	725.36M
Nika Pharmaceuticals	666.65M
Tian'an Technology Group	637.25M
CytoDyn	442.16M
Glass House Brands	419.90M
Northwest Biotherapeutics	394.88M

Market Cap Rankings